Flatuna

Quick links to important sections

Flatuna

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flatuna

What is Flatuna?

Flatuna is a pharmaceutical preparation used to manage symptoms associated with excess gas in the digestive tract. It is typically formulated as a combination of two active ingredients: simethicone and fungal diastase.

Composition and Mechanism

The components of Flatuna work through different mechanisms to address gastrointestinal discomfort:

  • Simethicone: This is an anti-foaming agent. It works by altering the surface tension of gas bubbles in the stomach and intestines. This causes smaller gas bubbles to coalesce into larger ones, which are then more easily expelled from the body through burping or passing flatus.
  • Fungal Diastase: This is a digestive enzyme that aids in the breakdown of carbohydrates and starch into simpler sugars. By assisting the natural digestive process, it helps prevent the fermentation of undigested food, which is a common cause of gas production.

Primary Use

Flatuna is primarily utilized to provide relief from abdominal pressure, bloating, and fullness caused by the accumulation of gas. It is often used in cases of indigestion or as a supportive treatment for various functional gastric disorders where gas retention is a prominent symptom.

What side effects are possible with Flatuna?

Possible Side Effects and Safety Information

The safety profile of Flatuna, containing Activated Charcoal and Simethicone, is characterized by effects primarily localized to the Gastrointestinal Disorders system, consistent with its non-systemic mechanism of action. Official regulatory documents classify side effects based on frequency and severity.


Officially Documented Adverse Reactions

The most common and expected side effect due to the activated charcoal component is the appearance of black stools (melena spurios). Other frequently reported gastrointestinal effects include constipation. Less common or rare effects may include diarrhoea, nausea, or vomiting. The possibility of rare immune system events, such as a hypersensitivity reaction (e.g., rash or swelling), is documented in line with general drug safety standards.


Regulatory Safety Constraints

The most clinically significant safety element is the explicit contraindication against use in patients with known or suspected intestinal obstruction, gastrointestinal bleeding, or after recent abdominal surgery. This restriction is mandated to prevent severe complications related to the presence of an adsorbent agent in the gut.

Drug-Drug Interaction Risk: A major regulatory safety note highlights that the adsorbent property of Activated Charcoal can reduce the absorption and effectiveness of other oral medications (such as certain oral contraceptives, cardiac medications, and antibiotics). This effect necessitates a required separation interval between the administration of Flatuna and any other oral drug.

Population-Specific Safety

Official labels advise caution for specific patient groups. Safety and efficacy are not fully established for all pediatric patients or for use during pregnancy and breastfeeding, often requiring specific medical guidance. The overall risk profile is defined by these local GI effects and the critical need to separate administration from other vital oral therapies.

Overdose and Emergency Response

Overdose and When to Seek Help

If you suspect an overdose of Flatuna, you must seek emergency medical treatment or contact a doctor or Poison Control Center immediately. Quick medical attention is critical, even if you do not notice any signs or symptoms. This product contains Simethicone and Activated Charcoal.

Simethicone is generally not absorbed by the body, meaning an overdose with this component alone is not expected to cause severe systemic toxicity. However, a significant ingestion of the product warrants attention due to the combination with Activated Charcoal. When Activated Charcoal is administered in emergency settings, its purpose is to absorb certain drugs or toxins in the digestive tract to prevent their absorption into the bloodstream.

While an overdose is generally classified as not likely to cause severe symptoms from the Simethicone component, the primary manifestations observed in cases of over-ingestion, especially in liquid forms, may include increased occurrences of vomiting and diarrhea. In the event these severe gastrointestinal symptoms are noticed, especially in children, immediate medical attention should be sought.

Do not attempt to self-treat a suspected overdose at home. The professional medical guidance is essential to properly assess the level of exposure, monitor the individual, and determine if any intervention is necessary based on the specific formulation and amount consumed.

Therapeutic Uses of Flatuna

Quick Facts

  • Addresses: Symptoms related to excess gas in the digestive tract.
  • Helps Manage: Bloating and abdominal discomfort.
  • Assists with: Gas-related pressure and fullness.

What Flatuna Treats: Main Uses and Benefits

Flatuna is indicated for the management of symptoms associated with excessive gas accumulation in the gastrointestinal system. It is utilized to provide relief from feelings of abdominal pressure, distension, and fullness, which are often reported as part of a gas-related upset.

The medication contains both simethicone and activated charcoal. Simethicone is considered to reduce the surface tension of gas bubbles, which may support their subsequent passage. The addition of activated charcoal may help to reduce the overall volume of intestinal gas and may adsorb certain substances in the digestive tract.

This formulation is applied in contexts of flatulence and associated digestive discomfort. The active components are used to address various gastrointestinal complaints, including belching and discomfort after meals. It is also used as an adjunct in preparatory regimens for diagnostic procedures, such as certain imaging studies, to help improve visualization by reducing gas shadows.

Eligibility and Restrictions for Use

Eligibility for Flatuna: Official Regulatory Status

Flatuna, which combines Activated Charcoal and Simethicone, is generally allowed for use in adults and teenagers (typically 12 years and older) seeking relief from gas-related discomfort. However, official regulatory documents define strict limitations on who must not use this medicine and who requires conditional use.

Absolute Contraindications

The medicine is contraindicated and must not be used by patients with:

  • A known hypersensitivity (allergy) to Simethicone, Activated Charcoal, or any excipients.
  • Underlying conditions that affect the integrity of the gastrointestinal tract, including intestinal obstruction (known or suspected), digestive tract bleeding, or recent abdominal surgery.
  • The presence of sudden or acute abdominal pain.

Restricted and Conditional Use

Population Group Regulatory Status Restriction Context (Official Labeling)
Children (under 12 years) Use not established / Not recommended Should be used only under the supervision of a doctor due to lack of established safety data for the combination product.
Pregnant Women Not fully established / Not recommended Should only be used if necessary and prescribed by a doctor.
Breastfeeding Women Not fully established / Not recommended Should only be used if necessary and prescribed by a doctor.

Eligibility is defined by these strict GI Integrity and Age-Based restrictions, rather than systemic conditions, as the active ingredients are not systemically absorbed.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile of this product, which contains Simethicone and Activated Charcoal, is primarily defined by the highly adsorptive nature of the Activated Charcoal component.

Interaction Type Interacting Products/Categories Regulatory Requirement/Constraint
Reduced Systemic Absorption All orally administered medicines intended for systemic absorption Must be separated by a minimum of 2 hours to avoid loss of efficacy.
Specific High-Risk Agents Mycophenolic acid, Mycophenolate Mofetil Classified as Severe interactions in official documents due to highly significant reduction in exposure.
Thyroid Hormones Levothyroxine and related thyroid replacement therapies Require strict separation to prevent decreased absorption, which may reduce the medicine's effectiveness.

The core constraint governing the use of this product is timing. Due to the capacity of activated charcoal to physically bind to and prevent the absorption of many orally taken medicines within the gastrointestinal tract, the official regulatory information mandates a minimum two-hour separation period between this product and any other medication. This procedural constraint is in place to preserve the systemic concentration and intended therapeutic effect of the co-administered drug. Failure to adhere to this required separation may result in a clinically significant reduction in the other drug's effectiveness.

Mechanism of Action

Flatuna's action is purely non-systemic, relying on physicochemical interactions localized entirely within the gastrointestinal (GI) lumen to facilitate gas clearance and decrease intraluminal pressure. The drug does not modulate human receptors or enzymes but operates through two complementary mechanical mechanisms.

Physical Neutralization of Trapped Gas (Simethicone)

This domain addresses the mechanism of changing the physical state of gas within the gut. Simethicone acts as a surfactant, reducing the interfacial tension of the gas-liquid boundary. This causes small, numerous gas bubbles (foam) to become unstable and coalesce into larger pockets, a physical change that results in larger gas pockets, which are mobilized via normal physiological clearance mechanisms.

Adsorption and Reduction of Gaseous Volume (Activated Charcoal)

This domain covers the subtractive mechanism of gas neutralization. Activated Charcoal functions as an intestinal adsorbent, using its vast internal surface area to physically adsorb free gas molecules and other irritants via van der Waals forces. The resulting reduction in the total volume of intraluminal gas directly decreases the pressure and physical distension exerted on the walls of the gut.

Mechanistic Synergy and Pressure Attenuation

The two mechanisms work synergistically: Simethicone mobilizes trapped gas into free gas, making it immediately available for adsorption by the charcoal component. This dual-action pathway leads to an efficient, combined neutralization of the gas load, decreasing the force exerted on the intestinal wall and attenuating the mechanical stimulus applied to gastrointestinal mechanoreceptors.

Dosage and Administration Information

How to Use Flatuna

The administration of Flatuna, a combination medicine containing Activated Charcoal and Simethicone, is categorized as a non-systemic agent. The route of administration is oral, encompassing both solid (tablet) and liquid (oral suspension) dosage forms.

Dosing and Administration Protocol

The dosing regimen is primarily structured for short-term symptomatic relief, with the maximum duration of continuous self-use limited to two weeks unless a health professional directs otherwise.

Parameter Principle of Use
Frequency Dosing is permitted as needed for acute symptoms, up to a maximum of four times daily.
Timing Administration is typically scheduled after meals and once more at bedtime.
Dose Limit Daily intake of the Simethicone component must not exceed 640 mg.
Pediatric Use Use in children under 12 years requires specific medical advice or supervision for dose determination.

Administration Conditions and Handling

Specific procedural steps are followed for correct intake. Liquid suspensions must be shaken vigorously before measuring the dose, and chewable tablets must be thoroughly chewed. A critical instruction is the requirement for time separation from other oral medications: due to the adsorptive properties of the charcoal component, Flatuna must be taken at least two hours before or one hour after any other oral medicine. Furthermore, if a scheduled dose is missed, the dose should be skipped, and the patient should return to the regular schedule without doubling the subsequent dose. These instructions define the standardized approach for the medicine's proper use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flatuna

The following overview summarizes the types of clinical and observational research that have been conducted on the combination of Activated Charcoal and Simethicone, detailing the areas studied, the populations included, and what remains uncertain in the evidence base, as reported in regulatory and peer-reviewed sources.

Evidence for Use in Functional Dyspepsia (Gas/Bloating Dominant)

Research has been conducted evaluating symptoms associated with Functional Dyspepsia (FD), a condition characterized by persistent or recurring discomfort in the upper abdomen. Studies exploring this context typically involve intermediate-term Randomized Controlled Trials (RCTs), many of which are double-blind and placebo-controlled. These trials were applied in research contexts involving fluctuating or unstable symptoms, and populations included adults who met recognized diagnostic criteria for FD.

Studies monitored patient-reported outcomes describing perceived discomfort, focusing on measuring changes in the severity of individual symptoms like post-prandial fullness, abdominal bloating, and epigastric discomfort. The research has monitored how symptoms changed over the defined study periods, often lasting up to three months. Findings describe patterns observed in the studies related to the change of these symptoms in the observed populations. Evidence is characterized as Moderate for this application by study design.

Evidence for Use in General Gaseous Abdominal Symptoms

Research has explored the combination product for general, non-specific complaints of bloating, abdominal pressure, and flatulence. These evaluations often take the form of short-term RCTs and controlled clinical trials, where studies monitored changes in patient-reported outcomes describing perceived discomfort. The studies monitored short-term symptom changes, with findings describing patterns related to the intensity and frequency of gaseous complaints over treatment intervals of 10 to 30 days. Evidence comes from studies that monitored symptom patterns, particularly those related to physical discomfort. Sample sizes were modest in some of the older trials.

Research Gaps and Unanswered Questions About Flatuna

The evidence landscape contributes to understanding symptom patterns, but several uncertainties remain. Comparative evidence is lacking in terms of studies that directly evaluate whether the combination provides a better pattern of symptom evolution than taking only one of the active ingredients. Follow-up durations were limited in many studies, meaning the data available for long-term effects are not fully established.

Key Studies & References

  1. The Role of Simethicone in Upper Gastrointestinal Endoscopy and Functional Dyspepsia

Frequently Asked Questions (FAQ)

Common questions about Flatuna (FAQ)


Q: Is Flatuna similar to other common treatments for the same condition?

Flatuna is described in official documents as a combination medicine that contains two active ingredients: an intestinal adsorbent (Activated Charcoal) and an antiflatulent (Simethicone). This dual composition is notable because it provides two complementary mechanisms of action. This differs from many common over-the-counter remedies that often contain only one of these active ingredients.


Q: Are there any long-term health concerns associated with using Flatuna?

Official regulatory guidance defines this medicine for short-term relief of symptoms, and self-use is generally limited to a maximum duration of two weeks. This short-term usage is noted because official studies have not fully established the long-term effects of the combination product.


Q: Is there a different name for the active ingredient in Flatuna?

The active ingredients are Activated Charcoal and Simethicone. Activated Charcoal is recognized for its ability to adsorb gas, while Simethicone is classified as a synthetic silicone compound that helps gas bubbles coalesce. These names are consistently used across regulatory materials to identify the components of the product.


Q: Does Flatuna interact with common pain relievers like ibuprofen?

Official information mandates that Flatuna must be separated from all orally administered medicines by a time interval of at least two hours. This rule applies generally to every medicine taken by mouth, including common pain relievers. The separation time is required because the Activated Charcoal component may physically bind to other drugs in the gut, which could potentially reduce their absorption and effectiveness.


Q: Can I stop taking Flatuna as soon as I feel better?

While Flatuna is permitted for short-term, as-needed use, official information requires separation. Flatuna is indicated for the symptomatic relief of gas and discomfort. Use is intended to be for the short term, and dosing is permitted as needed for acute symptoms. According to regulatory protocols, the medicine is not intended for continuous, long-term use.


Q: What is the difference between Flatuna and an over-the-counter remedy for gas?

Flatuna is categorized as an antiflatulent and intestinal adsorbent combination drug due to its dual active ingredients. The regulatory status of this product, whether it is available over-the-counter (OTC) or requires a prescription, can vary by country or specific region, depending on local regulatory classification.


Q: Can Flatuna be crushed or chewed?

Official documentation describes specific handling for different dosage forms. Instructions state that liquid suspensions must be shaken and chewable tablets must be thoroughly chewed. Non-chewable tablets are often described as being swallowed whole, and official documentation should be consulted for the specific instructions for your product.


Q: Is it possible to take too much Flatuna?

Official instructions define a maximum daily dose limit for the Simethicone component to help prevent overuse. Furthermore, regulatory protocols advise that if a dose is missed, it should be skipped rather than doubled. Regulatory documents describe the adherence to prescribed limits as part of standardized use protocols.


Q: Can Flatuna be taken with vitamins or dietary supplements?

Flatuna must be taken at least two hours before or one hour after any other oral product, including vitamins and dietary supplements. This is due to the Activated Charcoal component. This rule is in place because the required time separation may help preserve the systemic absorption and intended action of the supplement or vitamin.


Q: Are there different strengths or formulations of Flatuna?

The medicine is available in officially approved dosage forms including solid tablets and liquid oral suspensions. Depending on the product license and the manufacturer, different strengths of the combination product may also be available.


Q: What happens if I take Flatuna with a large meal?

Official administration instructions specify that dosing is typically scheduled after meals and at bedtime. Official information does not specifically describe the effect of a large meal on its action, but adherence to the prescribed timing relative to meals is recommended for standardized use.


Q: What is the shelf life of Flatuna?

The official labeling provides detailed storage instructions, requiring the product to be kept tightly closed and protected from light, heat, and moisture. The specific expiration date, which indicates the end of the product's shelf life, is a commercial detail that is always printed on the product packaging.


Q: Does Flatuna interact with alcohol?

Official product information is not universally consistent on this topic. In some sources, official product labeling may advise patients to avoid or limit alcohol consumption while taking the medication. In others, the interaction with alcohol is described as unknown or is not specified.


Q: Is Flatuna safe to use if I am driving or operating machinery?

Official product labeling typically states that this medicine is not usually expected to impair the ability to drive or operate machinery. However, official warnings note that if a person experiences side effects such as dizziness or drowsiness, caution is generally recommended.


Q: Is Flatuna described as addictive or habit-forming?

No. Official safety profiles note that there is no known risk of addiction or dependency with this medicine. Regulatory safety profiles indicate that this medicine does not contain substances classified as habit-forming.


Q: How quickly should Flatuna start working?

Because of its physical action in the gut, the effect of the medicine may be observed rapidly after administration. Some components are described in regulatory documents as beginning to act and provide symptomatic relief within 30 minutes of being taken.


Q: How long does the effect of one dose of Flatuna typically last?

According to official product descriptions in some regulatory sources, the effect of a single dose of this medicine is typically described as lasting for up to three to four hours after administration.


Q: Is it common to feel tired after taking Flatuna?

Official product labeling indicates that fatigue or tiredness is not typically listed among the commonly documented side effects of this medicine. Consistent with its non-systemic action, the medicine is not generally known to cause central nervous system effects such as sleepiness or drowsiness.


Q: Does Flatuna affect my ability to sleep?

The medicine is not known to cause sleepiness. Official product descriptions sometimes describe taking a dose at bedtime as an administration option to help manage discomfort caused by gas. This is done to help promote comfort during a period of rest.


Q: Are the side effects of Flatuna usually temporary?

Official product information generally describes side effects as temporary, localized, and related to the medicine’s non-systemic action. These effects are generally expected to resolve quickly when use of the medicine is discontinued.


Q: Can Flatuna be used by people who have liver problems?

Since this medicine's action is purely non-systemic, it is not absorbed into the body and works only in the gastrointestinal tract. As the medicine’s action is non-systemic, the regulatory profile does not list liver injury as an expected side effect.


Q: Why are there warnings about kidney function and Flatuna?

Regulatory documents do not typically prioritize warnings regarding kidney function on the product label for this medicine. As the medicine’s action is purely non-systemic and is not absorbed into the body, the regulatory profile does not list kidney injury as an expected side effect.

How should Flatuna be stored and disposed of?

Flatuna must be stored according to the requirements specified in the medicine's regulatory labeling to protect the stability of the Simethicone and Activated Charcoal components.

Storage Conditions

The product must be stored at controlled room temperature, defined as 20 C to 25 C (68 F to 77 F). The container must be kept tightly closed in its original packaging and be protected from light, excessive heat, and moisture.

  • Prohibited Environments: The official instructions state that the medicine must not be frozen.
  • Child Safety: Flatuna must be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused Flatuna must be disposed of safely. The primary method recommended by regulatory guidance is to use a drug take-back program or an authorized collection site.

If a take-back option is unavailable, the product should be removed from its container, mixed with an undesirable substance (such as dirt or used coffee grounds), placed in a sealed bag, and discarded with household trash. Flatuna must not be flushed down a toilet or poured down a sink drain, as the active ingredients are not on the FDA's list of medicines recommended for flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flatuna found in:

A-Z Index: